William J. Sandborn
2022
In 2022, William J. Sandborn earned a total compensation of $7.5M as President and Chief Medical Officer at Ventyx Biosciences.
Compensation breakdown
| Bonus | $175,000 |
|---|---|
| Non-Equity Incentive Plan | $337,500 |
| Option Awards | $6,580,000 |
| Salary | $322,917 |
| Other | $36,839 |
| Total | $7,452,256 |
Sandborn received $6.6M in option awards, accounting for 88% of the total pay in 2022.
Sandborn also received $175K in bonus, $337.5K in non-equity incentive plan, $322.9K in salary and $36.8K in other compensation.
Rankings
In 2022, William J. Sandborn's compensation ranked 381st out of 5,760 executives tracked by ExecPay. In other words, Sandborn earned more than 93.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 381 out of 5,760 | 93rd |
Division Manufacturing | 153 out of 3,136 | 95th |
Major group Chemicals And Allied Products | 39 out of 1,422 | 97th |
Industry group Drugs | 28 out of 1,323 | 98th |
Industry Pharmaceutical Preparations | 20 out of 969 | 98th |
Source: SEC filing on April 26, 2023.
Sandborn's colleagues
We found two more compensation records of executives who worked with William J. Sandborn at Ventyx Biosciences in 2022.